Virtu Financial’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Virtu Financial’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-48,708	Closed	-$77K	–	2088
2024 Q1	$77K	Buy	+48,708	New	+$72.2K	0.01%	960
2023 Q4	–	Sell	-10,754	Closed	-$12K	–	2168
2023 Q3	$12K	Buy	+10,754	New	+$22.3K	﹤0.01%	1088

Virtu Financial's NGM Position: Q2 2024 in Review

Virtu Financial sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 48,708 shares — an estimated $77K sold.

Virtu Financial first reported a position in NGM in Q3 2023 and held it in 2 quarters. The position peaked at $77K in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Virtu Financial reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Virtu Financial sold 48,708 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $77K.
Virtu Financial first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Virtu Financial's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $77K in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.